While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...

The healthcare giant raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from its previous outlook of ...

Shares of CVS Health jumped on Thursday after the healthcare giant posted better-than-expected second-quarter results and ...

CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin ...

CVS Health shares rose 2.7% after quarterly results beat Wall Street's estimates and the company raised its outlook for the year. Shares were trading around $63.97. The stock is up about 42% on the ...

Aetna saw its medical benefits ratio increase months after CVS announced it would exit the ACA individual market due to struggling performance.

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

Stock futures ticked higher Thursday morning, buoyed by blockbuster tech earnings that helped offset Fed signals casting doubt on a potential September rate cut ...

CVS beats Q2 earnings and revenue estimates, lifts full-year forecast. Stock surges over 8% in premarket trading, up 39% YTD.

In a statement, CVS Chief Executive David Joyner highlighted "a significant and durable recovery" at Aetna, and "strong retention" at CVS Caremark. Last quarter, CVS said that Aetna is exiting the ...

CVS Health (CVS) stock gains as the company beats Q2 2025 forecasts with strong insurance and pharmacy performance, and ...